1. Home
  2. ORN vs NLSP Comparison

ORN vs NLSP Comparison

Compare ORN & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORN
  • NLSP
  • Stock Information
  • Founded
  • ORN 1994
  • NLSP 2015
  • Country
  • ORN United States
  • NLSP Switzerland
  • Employees
  • ORN N/A
  • NLSP N/A
  • Industry
  • ORN Military/Government/Technical
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORN Industrials
  • NLSP Health Care
  • Exchange
  • ORN Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • ORN 350.4M
  • NLSP 12.4M
  • IPO Year
  • ORN 2007
  • NLSP 2021
  • Fundamental
  • Price
  • ORN $9.60
  • NLSP $2.50
  • Analyst Decision
  • ORN Strong Buy
  • NLSP
  • Analyst Count
  • ORN 2
  • NLSP 0
  • Target Price
  • ORN $11.25
  • NLSP N/A
  • AVG Volume (30 Days)
  • ORN 363.8K
  • NLSP 411.8K
  • Earning Date
  • ORN 07-23-2025
  • NLSP 07-15-2025
  • Dividend Yield
  • ORN N/A
  • NLSP N/A
  • EPS Growth
  • ORN N/A
  • NLSP N/A
  • EPS
  • ORN 0.08
  • NLSP N/A
  • Revenue
  • ORN $824,375,000.00
  • NLSP N/A
  • Revenue This Year
  • ORN $4.34
  • NLSP N/A
  • Revenue Next Year
  • ORN $11.09
  • NLSP N/A
  • P/E Ratio
  • ORN $121.20
  • NLSP N/A
  • Revenue Growth
  • ORN 15.58
  • NLSP N/A
  • 52 Week Low
  • ORN $4.64
  • NLSP $1.30
  • 52 Week High
  • ORN $12.12
  • NLSP $15.59
  • Technical
  • Relative Strength Index (RSI)
  • ORN 71.82
  • NLSP 52.64
  • Support Level
  • ORN $8.77
  • NLSP $2.16
  • Resistance Level
  • ORN $9.42
  • NLSP $3.08
  • Average True Range (ATR)
  • ORN 0.34
  • NLSP 0.24
  • MACD
  • ORN 0.01
  • NLSP -0.00
  • Stochastic Oscillator
  • ORN 99.18
  • NLSP 30.21

About ORN Orion Group Holdings Inc. Common

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar and mesh across the light commercial, structural and other associated business areas.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: